Wang Wen-Lun, Chang Wei-Lun, Yang Hsiao-Bai, Chang I-Wei, Lee Ching-Tai, Chang Chi-Yang, Lin Jaw-Town, Sheu Bor-Shyang
Institute of Clinical Medicine, National Cheng Kung University Medical Center, Tainan, Taiwan; Department of Internal Medicine, E-Da Hospital/I-Shou University, Kaohsiung, Taiwan.
Institute of Clinical Medicine, National Cheng Kung University Medical Center, Tainan, Taiwan; Department of Internal Medicine, National Cheng Kung University Medical Center, Tainan, Taiwan.
Oral Oncol. 2015 Jul;51(7):698-703. doi: 10.1016/j.oraloncology.2015.04.015. Epub 2015 May 7.
Patients with squamous cell carcinomas (SCC) of upper aerodigestive tract, either over head and neck (HNSCC) or esophagus (ESCC), frequently developed synchronous multiple cancers, leading to worse prognosis. This study validated whether suppression of host cancer immunosurveillance mediated by regulatory T cells (Treg) may predispose to the development of synchronous cancers.
Tumor tissues of 200 patients (100 ESCC only, 50 HNSCC only, and 50 synchronous SCCs) were quantitatively accessed for the tumor infiltrating Treg by immunohistochemistry. The density of Treg was also correlated to the level of Treg-associated inhibitory cytokines (IL-10, IL-35 and TGF-β1), and chemokine (CCL22).
The density of tumor infiltrating Treg in the index tumor (i.e. the first malignancy diagnosed) of synchronous SCC group was higher than those of HNSCC or ESCC only (p<0.05). Selecting the optimal cut-off value of Treg density as 34.6 cells/mm(2) by ROC curve, an increased Treg density of the index tumor can be an independent factor for developing synchronous SCCs (OR: 6.13; 95% CI: 2.84-13.26). The Treg density was positively correlated with serum IL-10 level and the degree of CCL22-positive cells infiltration in tumor. Furthermore, the serum inhibitory cytokine IL-10 level was higher in synchronous SCC than in non-synchronous ones (p<0.001), that indicated the cellular immunosuppression in patients with synchronous cancers.
A more severe defect in cellular immunity may predispose to multifocal tumor. The Treg cell number in SCC may serve as a novel predictive biomarker for the risk of synchronous cancer development to initiate a proper surveillance program.
上消化道鳞状细胞癌(SCC)患者,无论是头颈部(HNSCC)还是食管(ESCC),常发生同步性多发癌,导致预后更差。本研究验证了由调节性T细胞(Treg)介导的宿主癌症免疫监视抑制是否可能易患同步性癌症。
通过免疫组织化学对200例患者(仅100例ESCC、仅50例HNSCC和50例同步性SCC)的肿瘤组织进行肿瘤浸润Treg的定量分析。Treg的密度也与Treg相关抑制性细胞因子(IL-10、IL-35和TGF-β1)以及趋化因子(CCL22)的水平相关。
同步性SCC组的指数肿瘤(即首次诊断的恶性肿瘤)中肿瘤浸润Treg的密度高于仅HNSCC或ESCC组(p<0.05)。通过ROC曲线将Treg密度的最佳截断值选择为34.6个细胞/mm²,指数肿瘤中Treg密度增加可能是发生同步性SCC的独立因素(OR:6.13;95%CI:2.84 - 13.26)。Treg密度与血清IL-10水平以及肿瘤中CCL22阳性细胞浸润程度呈正相关。此外,同步性SCC患者的血清抑制性细胞因子IL-10水平高于非同步性患者(p<0.001),这表明同步性癌症患者存在细胞免疫抑制。
细胞免疫中更严重的缺陷可能易患多灶性肿瘤。SCC中Treg细胞数量可作为同步性癌症发生风险的新型预测生物标志物,以启动适当的监测程序。